Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-0.73	42.47	42.78
Graham Fair Price	< 0.005	1.41	1.41
PEG	inf	0.00	-6.85
Price/Book	-1.00	3.92	3.96
Price/Cash Flow	-1.00	67.24	67.92
Prices/Earnings	-1.00	16.33	16.50
Price/Sales	-1.00	10.04	10.14
Price/FCF	-1.00	67.24	67.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.45	0.45
Operating Margin	0.00	0.21	0.21
ROA	0.00	0.03	0.03
ROE	0.06	0.06	< 0.005
ROIC	0.04	0.04	-0.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.02	0.38	-94.99
Dividends QOQ	0.92	0.00	inf
EBIT QOQ	-0.11	0.00	inf
EPS QOQ	-0.02	0.00	inf
FCF QOQ	-0.17	0.00	inf
Revenue QOQ	-0.07	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.95	79.95	0.00
Days Sales Outstanding (DSO)	14.28	14.28	0.00
Inventory Turnover	1.13	1.13	0.00
Debt/Capitalization	0.35	0.35	1.23
Quick Ratio	0.68	0.68	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.21	1.21	< 0.005
Cash	0.55	0.55	0.00
Capex	-0.01	-0.01	0.00
Free Cash Flow	0.07	0.07	0.00
Revenue	0.47	0.47	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.01	1.01	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.87	0.98	12.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating